Publications by authors named "Mohannad Abdulrahman Aljehani"
Article Synopsis
- NAFLD is a growing health concern with no specific FDA-approved treatments currently available.
- A search of ClinicalTrials.gov identified 31 eligible interventional studies, with 19 selected for detailed evaluation, primarily from Korea and China.
- Medications like metformin, Exenatide, and Pioglitazone were among the most studied interventions, highlighting the need for continued research into effective treatments for NAFLD.
Resolved Hypereosinophilic Syndrome and Immune Thrombocytopenic Purpura in Ulcerative Colitis Patients Post Colectomy: A Case Series and Literature Review.
Ahmed Hussein Subki Manal Ismail Bokhary Sultan Abdulrahman Alandijani Mohannad Abdulrahman Aljehani Ahmed Wasel Alharbi
J Inflamm Res
November 2022
Article Synopsis
- Hypereosinophilic syndrome (HES) and immune thrombocytopenic purpura (ITP) can occur alongside ulcerative colitis (UC), but their exact causes are not well understood.
- Two case studies of UC patients are presented, one who had HES and another with ITP, both of which did not respond to standard treatments.
- The patients showed significant improvement after undergoing colectomy, indicating that their conditions might be reactive to UC rather than idiopathic.